Show simple item record

dc.contributor.authorMelagraki, G.en
dc.contributor.authorAfantitis, Antreasen
dc.contributor.authorSarimveis, H.en
dc.contributor.authorKoutentis, Panayiotis Andreasen
dc.contributor.authorKollias, G.en
dc.contributor.authorIgglessi-Markopoulou, O.en
dc.creatorMelagraki, G.en
dc.creatorAfantitis, Antreasen
dc.creatorSarimveis, H.en
dc.creatorKoutentis, Panayiotis Andreasen
dc.creatorKollias, G.en
dc.creatorIgglessi-Markopoulou, O.en
dc.date.accessioned2019-11-21T06:21:26Z
dc.date.available2019-11-21T06:21:26Z
dc.date.issued2009
dc.identifier.issn1381-1991
dc.identifier.urihttp://gnosis.library.ucy.ac.cy/handle/7/55845
dc.description.abstractA linear Quantitative Structure-Activity Relationship (QSAR) is developed in this work for modeling and predicting HDAC inhibition by 5-pyridin-2-yl- thiophene-2-hydroxamic acids. In particular, a five-variable model is produced by using the Multiple Linear Regression (MLR) technique and the Elimination Selection-Stepwise Regression Method (ES-SWR) on a database that consists of 58 recently discovered 5-pyridin-2-yl-thiophene-2-hydroxamic acids and 69 descriptors. The physical meaning of the selected descriptors is discussed in detail. The validity of the proposed MLR model is established using the following techniques: cross validation, validation through an external test set and Y-randomization. Furthermore, the domain of applicability which indicates the area of reliable predictions is defined. Based on the produced model, an in silico-screening study explores novel structural patterns and suggests new potent lead compounds. © 2009 Springer Science+Business Media B.V.en
dc.sourceMolecular diversityen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-68349126938&doi=10.1007%2fs11030-009-9115-2&partnerID=40&md5=a928b5b71b4af9c85f15be39a7c1b9e6
dc.subjectComputer Simulationen
dc.subjectarticleen
dc.subjectAlgorithmsen
dc.subjectRegression Analysisen
dc.subjectpriority journalen
dc.subjectReproducibility of Resultsen
dc.subjectdrug activityen
dc.subjectdrug screeningen
dc.subjectEnzyme Inhibitorsen
dc.subjectPyridinesen
dc.subjectphysical chemistryen
dc.subjectPhysicochemical Phenomenaen
dc.subjectIC 50en
dc.subjectDrug Discoveryen
dc.subjectdrug inhibitionen
dc.subjectQSARen
dc.subjectquantitative structure activity relationen
dc.subjectQuantitative Structure-Activity Relationshipen
dc.subjectdrug structureen
dc.subjectHDACen
dc.subjectHistone Deacetylase Inhibitorsen
dc.subjectModels, Chemicalen
dc.subjectmultiple linear regression analysisen
dc.subjectThiophenesen
dc.subjectIn silico screeningen
dc.subjecthistone deacetylase inhibitoren
dc.subjectHistone deacetylasesen
dc.subjectHydroxamic acidsen
dc.titlePredictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitorsen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s11030-009-9115-2
dc.description.volume13
dc.description.issue3
dc.description.startingpage301
dc.description.endingpage311
dc.author.faculty002 Σχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences
dc.author.departmentΤμήμα Χημείας / Department of Chemistry
dc.type.uhtypeArticleen
dc.description.notes<p>Cited By :35</p>en
dc.source.abbreviationMol.Diversityen
dc.contributor.orcidKoutentis, Panayiotis Andreas [0000-0002-4652-7567]
dc.contributor.orcidAfantitis, Antreas [0000-0002-0977-8180]
dc.contributor.orcidIgglessi-Markopoulou, O. [0000-0002-7683-8526]
dc.gnosis.orcid0000-0002-4652-7567
dc.gnosis.orcid0000-0002-0977-8180|0000-0002-7683-8526


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record